FDA Inspection 854124 — Ursapharm Arzneimittel GmbH

Ursapharm Arzneimittel GmbH — FEI 3004978466

The FDA completed an inspection of Ursapharm Arzneimittel GmbH on September 13, 2013 in Saarbrucken. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 13, 2013
Fiscal Year
2013
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Saarbrucken (Germany)

Citations

IDCFRDescription
145121 CFR 211.113(b)Procedures for sterile drug products